Amicus Therapeutics IncLatest Amicus Therapeutics Inc News and UpdatesCompany & Industry OverviewsAnalyzing the Market Potential for Amicus’s GalafoldAccording to Amicus Therapeutics, the annual incidence of the disease in newborn males is estimated to be between 1:40,000 and 1:60,000.
Company & Industry OverviewsAnalyzing the Market Potential for Amicus’s GalafoldAccording to Amicus Therapeutics, the annual incidence of the disease in newborn males is estimated to be between 1:40,000 and 1:60,000.
